Alliance Pharma board backs final GBP362 million takeover bid
10th Mar 2025 10:51
(Alliance News) - Alliance Pharma PLC on Monday said it has agreed to a final increased cash offer of 64.75 pence per share from Dbay Advisors Ltd and Edmond de Rothschild Equity Strategies IV SLP, also known as Eres IV Fund, valuing the company at GBP362.0 million. Read More